ADAM10 plasma levels predict worsening in cognition of older adults: a 3-year follow-up study

BACKGROUND: Blood-based biomarkers for Alzheimer’s disease (AD) are highly needed in clinic practice. So far, the gold standards for AD diagnosis are brain neuroimaging and beta-amyloid peptide, total tau, and phosphorylated tau in cerebrospinal fluid (CSF); however, they are not attractive for larg...

Descripción completa

Detalles Bibliográficos
Autores principales: Oliveira Monteiro, Maria Patrícia A., Salheb Oliveira, Danielle S. M., Manzine, Patrícia R., Crispim Nascimento, Carla M., dos Santos Orlandi, Ariene A., de Oliveira Gomes, Grace A., dos Santos Orlandi, Fabiana, Zazzetta, Marisa S., Pott-Junior, Henrique, Cominetti, Marcia R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7792035/
https://www.ncbi.nlm.nih.gov/pubmed/33419480
http://dx.doi.org/10.1186/s13195-020-00750-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7792035/
https://www.ncbi.nlm.nih.gov/pubmed/33419480
http://dx.doi.org/10.1186/s13195-020-00750-y

Ejemplares similares